TCMD's revenue growth has decelerated from peak rates of 21.0% to 7.1% year-over-year in 2026Q3, while gross margins have held between 68.7% and 76.5%, yet trailing operating margin of roughly 8.9% suggests limited operating leverage as SG&A absorbs 63% to 78% of gross profit.
Price trend, volume and key moving averages
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Nov 2, 2026 | $0.31+12.0% vs $0.28 | $92M-0.1% vs $92M |
Q3 2026 Aug 10, 2026 | $0.34+151.9% vs $0.14 | $86M+0.2% vs $86M |
Q2 2026 May 4, 2026 | -$0.08-14.3% vs -$0.07 | $75M+6.7% vs $71M |
Q1 2026 Feb 17, 2026 | $0.46+4.5% vs $0.44 | $104M+10.4% vs $94M |
MINNEAPOLIS, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that third quarter of fiscal year 2026 financial results will be released after the market closes on Monday, November 2, 2026.
Tactile Systems Technology (NASDAQ: TCMD - Get Free Report) and Zynex (NASDAQ: ZYXI - Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, risk, institutional ownership, valuation, dividends and profitability. Earnings and Valuation This table compares Tactile
Tactile Systems Technology, Inc. (TCMD) Q2 2026 Earnings Call Transcript
Tactile Systems Technology NASDAQ: TCMD, doing business as Tactile Medical, reported second-quarter revenue growth and higher profitability, led by its lymphedema business, while updating its full-year outlook to reflect temporary inventory effects in its airway-clearance segment.
Benchmark TCMD against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Tactile Systems Technology, Inc. (TCMD)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $26.03 | $587.14M | 25.19 | 12.47% | 6.68% | 10.73% | — | |
| $100.61 | $6.55B | 25.50 | 0.5% | 17.28% | 21.72% | — | |
| $126.56 | $4.3B | 42.23 | 7.57% | 5.68% | 6.02% | — | |
| $87.23 | $5.2B | 32.89 | 11.66% | 9.94% | 9.65% | — | |
| $51.50 | $1.54B | 21.13 | 5.16% | 5.36% | 7.07% | 1.54% | |
| $58.54 | $2.98B | 195.98 | 14.88% | 2.52% | 2.93% | — |
Tactile Systems Technology, Inc. (TCMD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Tactile Systems Technology, Inc. (TCMD) SEC filings — annual & quarterly reports (10-K, 10-Q)
Nov 2, 2026·SEC
Aug 10, 2026·SEC
Jul 13, 2026·SEC
Get notified when TCMD posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Tactile Systems Technology, Inc. (TCMD) stock FAQ — growth, dividends, profitability & financials explained
Tactile Systems Technology, Inc. (TCMD) reported $356.4M in revenue over the trailing twelve months. Revenue was $329.5M in fiscal year 2025. That is 786% more than the $37.2M of fiscal year 2013.
Tactile Systems Technology, Inc. (TCMD) grew revenue by 14.4% over the trailing twelve months, compared with the twelve months before.
Yes. Tactile Systems Technology, Inc. (TCMD) earned $23.8M in net income over the trailing twelve months (a 6.7% net margin).
Tactile Systems Technology, Inc. (TCMD) had a return on equity (ROE) of 10.7% over the trailing twelve months. That is in line with the market's typical 10-15%.
Tactile Systems Technology, Inc. (TCMD) generated $29.0M in free cash flow over the trailing twelve months.
